Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Batteries Not Included: P&G Plans Duracell Divestiture

This article was originally published in The Tan Sheet

Executive Summary

The firm’s plan to splin off or otherwise divest Duracell raises the question of whether billion dollar brands could follow. Separately, the firm confirms that Melanie Healey, North America head of operations – previously seen as a potential candidate to succeed current CEO A.G. Lafley – will retire in June 2015.

You may also be interested in...



P&G Leaves Divesting Out Of Value-Building Tool Box – CFO

P&G CFO Jon Moeller says splitting up or spinning off business units is a relevant question, but is a short-term approach while the firm is focused on long-term value building through innovation. During an investor conference, he also discusses plans to boost promotional spending.

P&G Leaves Divesting Out Of Value-Building Tool Box – CFO

P&G CFO Jon Moeller says splitting up or spinning off business units is a relevant question, but is a short-term approach while the firm is focused on long-term value building through innovation. During an investor conference, he also discusses plans to boost promotional spending.

P&G Eyes Expanded Gillette Skin Care And Hair Care Offerings

Procter & Gamble will focus on growing Gillette's brand equity and product offerings in the mid term, P&G CFO Clayt Daley told analysts during an Oct. 3 conference call. P&G's $57 bil. acquisition of Gillette closed Oct. 1, one day after receiving FTC approval

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107235

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel